Literature DB >> 271143

Further evidence for a non-random chromosomal abnormality in acute promyelocytic leukemia.

J D Rowley, H M Golomb, J Vardiman, S Fukuhara, C Dougherty, D Potter.   

Abstract

We have previously reported on two patients with acute promyelocytic leukemia (APL) who had what appeared to be a deletion of chromosome No. 17. We now describe a third patient with APL. All three patients had a structural rearrangement involving No. 15 and No. 17. Our current interpretation of the chromosomal abnormality is that it is a reciprocal translocation, t (15;17) (q22; q21). Evidence that this is a consistent rearrangement associated with APL comes not only from our three patients, but also from two other published cases of APL, studied with banding, who also had an identical abnormality.

Entities:  

Mesh:

Year:  1977        PMID: 271143     DOI: 10.1002/ijc.2910200608

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  25 in total

Review 1.  Genome sequencing and cancer.

Authors:  Elaine R Mardis
Journal:  Curr Opin Genet Dev       Date:  2012-04-23       Impact factor: 5.578

2.  The gene for human erythrocyte protein 4.2 maps to chromosome 15q15.

Authors:  V Najfeld; S G Ballard; J Menninger; D C Ward; E E Bouhassira; R S Schwartz; R L Nagel; A C Rybicki
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

3.  The nerve growth factor receptor gene is at human chromosome region 17q12-17q22, distal to the chromosome 17 breakpoint in acute leukemias.

Authors:  K Huebner; M Isobe; M Chao; M Bothwell; A H Ross; J Finan; J A Hoxie; A Sehgal; C R Buck; A Lanahan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

4.  The origin and evolution of mutations in acute myeloid leukemia.

Authors:  John S Welch; Timothy J Ley; Daniel C Link; Christopher A Miller; David E Larson; Daniel C Koboldt; Lukas D Wartman; Tamara L Lamprecht; Fulu Liu; Jun Xia; Cyriac Kandoth; Robert S Fulton; Michael D McLellan; David J Dooling; John W Wallis; Ken Chen; Christopher C Harris; Heather K Schmidt; Joelle M Kalicki-Veizer; Charles Lu; Qunyuan Zhang; Ling Lin; Michelle D O'Laughlin; Joshua F McMichael; Kim D Delehaunty; Lucinda A Fulton; Vincent J Magrini; Sean D McGrath; Ryan T Demeter; Tammi L Vickery; Jasreet Hundal; Lisa L Cook; Gary W Swift; Jerry P Reed; Patricia A Alldredge; Todd N Wylie; Jason R Walker; Mark A Watson; Sharon E Heath; William D Shannon; Nobish Varghese; Rakesh Nagarajan; Jacqueline E Payton; Jack D Baty; Shashikant Kulkarni; Jeffery M Klco; Michael H Tomasson; Peter Westervelt; Matthew J Walter; Timothy A Graubert; John F DiPersio; Li Ding; Elaine R Mardis; Richard K Wilson
Journal:  Cell       Date:  2012-07-20       Impact factor: 41.582

5.  Sequencing the AML genome, transcriptome, and epigenome.

Authors:  Elaine R Mardis
Journal:  Semin Hematol       Date:  2014-08-07       Impact factor: 3.851

6.  Interactions of herpes simplex virus type 1 with ND10 and recruitment of PML to replication compartments.

Authors:  J Burkham; D M Coen; C B Hwang; S K Weller
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

7.  The use of bone core biopsies for cytogenetic analysis.

Authors:  P Martin; J D Rowley; J M Baron
Journal:  Hum Genet       Date:  1979-10-01       Impact factor: 4.132

8.  Clinical aspects of acute myeloid leukemias of the FAB types M3 and M4Eo. The AML Cooperative Group.

Authors:  T Haferlach; W Gassmann; H Löffler; C Jürgensen; J Noak; W D Ludwig; E Thiel; D Haase; C Fonatsch; R Becher
Journal:  Ann Hematol       Date:  1993-04       Impact factor: 3.673

9.  Repeated complete remission in a patient with acute promyelocytic leukemia after treatment with 13-cis-retinoic acid first and with all-trans-retinoic acid in relapse.

Authors:  T Haferlach; H Löffler; B Glass; W Gassmann
Journal:  Clin Investig       Date:  1993-10

10.  The human c-ros gene (ROS) is located at chromosome region 6q16----6q22.

Authors:  L Nagarajan; E Louie; Y Tsujimoto; P C Balduzzi; K Huebner; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.